4
Changes in Ownership
CASTLE BIOSCIENCES INC Filed Acc 0001628280-26-065327
Pres. & Chief Exec. Officer sold 14,496 shares at $35.57 ($515,565)
- Pres. & Chief Exec. Officer acquired 8,165 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MAETZOLD DEREK J Pres. & Chief Exec. Officer | 2026-10-05 | Option exercise 10b5-1 | +8,165 | $2.39 | $19,514 | 29,644 | D |
| MAETZOLD DEREK J Pres. & Chief Exec. Officer | 2026-10-05 | Sale 10b5-1 | −8,580 | $35.57 | $305,156 | 21,064 | D |
| MAETZOLD DEREK J Pres. & Chief Exec. Officer | 2026-10-05 | Sale 10b5-1 | −3,198 | $35.57 | $113,740 | 8,038 | I |
| MAETZOLD DEREK J Pres. & Chief Exec. Officer | 2026-10-05 | Sale 10b5-1 | −2,718 | $35.57 | $96,668 | 6,832 | I |
| Derivatives | |||||||
| MAETZOLD DEREK J Pres. & Chief Exec. Officer | 2026-10-05 | Option exercise · Stock option (right to buy) 10b5-1 | −8,165 | 0 | D | ||
| Open-market sales · 14,496 sh · avg $35.57 · $515,565 | |||||||
Loading xslF345X06/wk-form4_1791403842.xml…